---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-020491"
form_type: "8-K"
ticker: "TGTX"
cik: "0001001316"
company_name: "TG THERAPEUTICS, INC."
filed_at: "2026-06-12T20:32:23+00:00"
generated_at: "2026-06-12T20:53:35.895811+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# TG Therapeutics say-on-pay fails at 2026 annual meeting; directors elected

## Summary
- Proposal 3 (say-on-pay): 48.9M votes against vs 31.9M in favor; not approved.
- All six director nominees elected; Sagar Lonial received 54.85% support, lowest.
- Ratification of KPMG as auditor approved: 112.3M for, 531.8K against.
- Quorum of 113.0M shares (73.81% of outstanding) present at June 11 meeting.

## SEC filing metadata
- accession: 0001437749-26-020491
- form_type: 8-K
- ticker: TGTX
- cik: 0001001316
- company_name: TG THERAPEUTICS, INC.
- filed_at: 2026-06-12T20:32:23+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1001316/000143774926020491/0001437749-26-020491-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1001316/000143774926020491/tgtx20260612_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-020491
- JSON: https://secwatch.observer/filing/0001437749-26-020491.json
- Plain text: https://secwatch.observer/filing/0001437749-26-020491.txt

## Key facts
- Shareholder Votes
  TG THERAPEUTICS, INC. shareholders approved Election of six directors to hold office until the 2027 annual meeting at the 2026-06-11 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-06-11
  source text: Proposal 1 The votes with respect to the election of the six directors to hold office until the 2027 annual meeting were as follows: Director Votes For % Voted For Votes Withheld % Voted Withheld Broker Non-Votes Michael S. Weiss 72,172,630 88.63% 9,260,279 11.37% 31,570,505 Laurence N. Charney 68,135,448 83.67% 13,297,461 16.33% 31,570,505 Yann Echelard 64,110,661 78.73% 17,322,248 21.27% 31,570,505 Kenneth Hoberman 53,354,717 65.52% 28,078,192 34.48% 31,570,505 Daniel Hume 63,979,535 78.57% 17,453,374 21.43% 31,570,505 Sagar Lonial, MD 44,666,544 54.85% 36,766,365 45.15% 31,570,505
  evidence_url: https://www.sec.gov/Archives/edgar/data/1001316/000143774926020491/0001437749-26-020491-index.htm
- Shareholder Votes
  TG THERAPEUTICS, INC. shareholders rejected Advisory vote to approve the compensation of the Company’s named executive officers at the 2026-06-11 meeting.
  - Proposal: say on pay
  - Outcome: failed
  - Meeting: 2026-06-11
  source text: Proposal 3 The advisory vote to approve the compensation of the Company’s named executive officers was as follows: Total Votes For Total Votes Against Abstentions Broker Non-Votes 31,905,837 48,858,169 668,903 31,570,505
  evidence_url: https://www.sec.gov/Archives/edgar/data/1001316/000143774926020491/0001437749-26-020491-index.htm
- Shareholder Votes
  TG THERAPEUTICS, INC. shareholders approved Ratification of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-11 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-06-11
  source text: Proposal 2 The vote with respect to the ratification of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was as follows: Total Votes For Total Votes Against Abstentions Broker Non-Votes 112,329,330 531,758 142,326 --
  evidence_url: https://www.sec.gov/Archives/edgar/data/1001316/000143774926020491/0001437749-26-020491-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.